Literature DB >> 1325211

Human neutrophils synthesize thrombomodulin that does not promote thrombin-dependent protein C activation.

E M Conway1, B Nowakowski, M Steiner-Mosonyi.   

Abstract

Thrombomodulin (TM) is a surface glycoprotein that forms a 1:1 complex with thrombin, thereby interacting to form the basis of a major physiologically relevant natural anticoagulant mechanism. Although initially described as a vascular endothelial cell receptor, TM has been reported to be present in several other cells, including megakaryocytes, platelets, monocytes, and several cultured cells. Other investigators have reported that neutrophils (PMN) may play a role in the hemostatic mechanism by supporting transformation of prothrombin to thrombin. To determine whether PMN might contribute further to the regulation of the coagulation system, we have evaluated these cells for the expression of TM. Large numbers of human leukocytes were isolated by standard techniques, and the PMN fraction was extracted and shown to be free of platelets and monocytes. Membrane preparations were affinity purified on an anti-TM-Affigel-10 matrix and the eluted material was examined by Western blotting, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and silver staining. The purified material was identical in apparent molecular weight to TM from human placenta and human umbilical vein endothelial cells (HUVEC). Using a sensitive and specific immunoassay, we estimated that there are a minimum of 5,220 +/- 1,658 molecules of TM per PMN, as compared with more than 50,000 in HUVEC. Northern analysis of RNA from PMN indicates that specific messenger RNA for TM, as identified by a single 3.8-kb band, is identical to that from HUVEC, and thereby confirms that PMN can also synthesize the receptor. Localization of TM in PMN was attempted by immunofluorescence, and the receptor was visualized only in permeabilized PMN, but was not seen on the surface of nonpermeabilized cells. Flow cytometry was also used, and could detect TM in 10% to 15% of nonpermeabilized PMN, whereas the antigen was present in greater than 80% of permeabilized cells. Biologic function of the PMN-derived TM, as tested by thrombin-dependent activation of protein C, was absent. Our results suggest that TM is synthesized by PMN, but under nonstimulated conditions, the protein is largely excluded from the membrane surface, and lacks the ability to promote activation of protein C by thrombin. TM from PMN may provide a further link between inflammation and thrombosis and may also be a significant source of plasma TM.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325211

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates.

Authors:  András Gruber; Ulla M Marzec; Leslie Bush; Enrico Di Cera; José A Fernández; Michelle A Berny; Erik I Tucker; Owen J T McCarty; John H Griffin; Stephen R Hanson
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

Review 2.  Thrombomodulin and its role in inflammation.

Authors:  Edward M Conway
Journal:  Semin Immunopathol       Date:  2011-07-31       Impact factor: 9.623

Review 3.  Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis.

Authors:  William H Robinson; Christin M Lepus; Qian Wang; Harini Raghu; Rong Mao; Tamsin M Lindstrom; Jeremy Sokolove
Journal:  Nat Rev Rheumatol       Date:  2016-08-19       Impact factor: 20.543

4.  Protein C concentrate controls leukocyte recruitment during inflammation and improves survival during endotoxemia after efficient in vivo activation.

Authors:  David Frommhold; Julia Tschada; Natascha Braach; Kirsten Buschmann; Axel Doerner; Johanna Pflaum; Marie-Sophie Stahl; Hongjie Wang; Lutz Koch; Markus Sperandio; Angelika Bierhaus; Berend Isermann; Johannes Poeschl
Journal:  Am J Pathol       Date:  2011-09-09       Impact factor: 4.307

5.  Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation.

Authors:  Edward M Conway; Femke Zwerts; Veerle Van Eygen; Astrid DeVriese; Nobuo Nagai; Wei Luo; Désiré Collen
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

6.  Thrombomodulin expression by human keratinocytes. Induction of cofactor activity during epidermal differentiation.

Authors:  T J Raife; D J Lager; K C Madison; W W Piette; E J Howard; M T Sturm; Y Chen; S R Lentz
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level.

Authors:  Veli Cobankara; Düzgün Ozatli; Sedat Kiraz; Mehmet Akif Oztürk; Ihsan Ertenli; Tufan Türk; Sule Apras; Ibrahim C Haznedaroglu; Meral Calgüneri
Journal:  Clin Rheumatol       Date:  2004-06-19       Impact factor: 2.980

8.  Cellular localization of thrombomodulin in human epithelium and squamous malignancies.

Authors:  D J Lager; E J Callaghan; S F Worth; T J Raife; S R Lentz
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

9.  Expression and localization of thrombomodulin in preneoplastic bronchial lesions and in lung cancer.

Authors:  E Tolnay; T Wiethege; K M Müller
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

10.  Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response.

Authors:  Chung-Sheng Shi; Guey-Yueh Shi; Hsi-Min Hsiao; Shi-Ming Hsiao; Yuan-Chung Kao; Kuan-Lin Kuo; Chih-Yuan Ma; Cheng-Hsiang Kuo; Bi-Ing Chang; Chuan-Fa Chang; Chun-Hung Lin; Chi-Huey Wong; Hua-Lin Wu
Journal:  Blood       Date:  2008-08-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.